WallStSmart

Amrize Ltd (AMRZ)vsCRH PLC ADR (CRH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CRH PLC ADR generates 220% more annual revenue ($38.06B vs $11.91B). AMRZ leads profitability with a 9.7% profit margin vs 9.7%. AMRZ appears more attractively valued with a PEG of 1.49. CRH earns a higher WallStSmart Score of 58/100 (C).

AMRZ

Hold

49

out of 100

Grade: D+

Growth: 4.0Profit: 5.0Value: 5.7Quality: 5.0
Piotroski: 2/9Altman Z: 1.61

CRH

Buy

58

out of 100

Grade: C

Growth: 7.3Profit: 5.5Value: 5.0Quality: 6.5
Piotroski: 4/9Altman Z: 2.16

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMRZ1 strengths · Avg: 8.0/10
Price/BookValuation
2.3x8/10

Reasonable price relative to book value

CRH3 strengths · Avg: 8.7/10
Market CapQuality
$73.23B9/10

Large-cap with strong market position

Return on EquityProfitability
21.9%9/10

Every $100 of equity generates 22 in profit

EPS GrowthGrowth
48.4%8/10

Earnings expanding 48.4% YoY

Areas to Watch

AMRZ4 concerns · Avg: 4.0/10
P/E RatioValuation
26.5x4/10

Moderate valuation

Revenue GrowthGrowth
4.7%4/10

4.7% revenue growth

EPS GrowthGrowth
3.6%4/10

3.6% earnings growth

Altman Z-ScoreHealth
1.614/10

Distress zone — elevated risk

CRH3 concerns · Avg: 2.3/10
PEG RatioValuation
2.024/10

Expensive relative to growth rate

Free Cash FlowQuality
$-1.22B2/10

Negative free cash flow — burning cash

Operating MarginProfitability
-0.0%1/10

Operating margin of -0.0%

Comparative Analysis Report

WallStSmart Research

Bull Case : AMRZ

The strongest argument for AMRZ centers on Price/Book. PEG of 1.49 suggests the stock is reasonably priced for its growth.

Bull Case : CRH

The strongest argument for CRH centers on Market Cap, Return on Equity, EPS Growth.

Bear Case : AMRZ

The primary concerns for AMRZ are P/E Ratio, Revenue Growth, EPS Growth.

Bear Case : CRH

The primary concerns for CRH are PEG Ratio, Free Cash Flow, Operating Margin.

Key Dynamics to Monitor

CRH is growing revenue faster at 9.1% — sustainability is the question.

AMRZ generates stronger free cash flow (-1.2B), providing more financial flexibility.

Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CRH scores higher overall (58/100 vs 49/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amrize Ltd

BASIC MATERIALS · BUILDING MATERIALS · USA

Amrize Ltd (AMRZ) is a pioneering technology company specializing in the digital health and wellness sector, committed to revolutionizing healthcare delivery through cutting-edge technologies and data-centric solutions. With a robust emphasis on enhancing patient outcomes and accessibility, Amrize allocates substantial resources to research and development, positioning itself to meet the escalating demand for scalable health innovations. Its strategic initiatives, coupled with a diverse portfolio of products, underscore Amrize's potential as a crucial player in the ongoing transformation of healthcare, offering an appealing investment opportunity for institutional investors in a dynamic market landscape.

Visit Website →

CRH PLC ADR

BASIC MATERIALS · BUILDING MATERIALS · USA

CRH plc manufactures and distributes construction materials. The company is headquartered in Dublin, Ireland.

Visit Website →

Want to dig deeper into these stocks?